Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Non volatile constituents of the vermouth ingredient Artemisia vallesiaca.

Pollastro F, Lopatriello A, Vouillamoz JF, Appendino G, Taglialatela-Scafati O, Forino M.

Fitoterapia. 2019 Aug 13;138:104312. doi: 10.1016/j.fitote.2019.104312. [Epub ahead of print]

PMID:
31419464
2.

Observed controls on resilience of groundwater to climate variability in sub-Saharan Africa.

Cuthbert MO, Taylor RG, Favreau G, Todd MC, Shamsudduha M, Villholth KG, MacDonald AM, Scanlon BR, Kotchoni DOV, Vouillamoz JM, Lawson FMA, Adjomayi PA, Kashaigili J, Seddon D, Sorensen JPR, Ebrahim GY, Owor M, Nyenje PM, Nazoumou Y, Goni I, Ousmane BI, Sibanda T, Ascott MJ, Macdonald DMJ, Agyekum W, Koussoubé Y, Wanke H, Kim H, Wada Y, Lo MH, Oki T, Kukuric N.

Nature. 2019 Aug;572(7768):230-234. doi: 10.1038/s41586-019-1441-7. Epub 2019 Aug 7.

PMID:
31391559
3.

Muropeptide signature of inhibitors of protein synthesis correlates with β-lactam synergism against methicillin-resistant Staphylococcus aureus.

Guignard B, Majcherczyk PA, Monachon C, Vouillamoz J, Moreillon P.

Int J Antimicrob Agents. 2017 Jan;49(1):53-61. doi: 10.1016/j.ijantimicag.2016.09.028. Epub 2016 Nov 16.

PMID:
27887965
4.

The génépi Artemisia species. Ethnopharmacology, cultivation, phytochemistry, and bioactivity.

Vouillamoz JF, Carlen C, Taglialatela-Scafati O, Pollastro F, Appendino G.

Fitoterapia. 2015 Oct;106:231-41. doi: 10.1016/j.fitote.2015.09.007. Epub 2015 Sep 8. Review.

PMID:
26358481
5.

Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA.

Veloso TR, Mancini S, Giddey M, Vouillamoz J, Que YA, Moreillon P, Entenza JM.

Vaccine. 2015 Jul 9;33(30):3512-7. doi: 10.1016/j.vaccine.2015.05.060. Epub 2015 Jun 3.

PMID:
26048778
6.

In vivo effect of flucloxacillin in experimental endocarditis caused by mecC-positive staphylococcus aureus showing temperature-dependent susceptibility in vitro.

Mancini S, Laurent F, Veloso TR, Giddey M, Vouillamoz J, Vandenesch F, Moreillon P, Entenza JM.

Antimicrob Agents Chemother. 2015 Apr;59(4):2435-8. doi: 10.1128/AAC.04733-14. Epub 2015 Jan 20.

7.

Assessment of the in vitro synergy of daptomycin plus linezolid against multidrug-resistant enterococci.

Entenza JM, Giddey M, Vouillamoz J, Moreillon P, Mancini S.

J Glob Antimicrob Resist. 2014 Dec;2(4):306-308. doi: 10.1016/j.jgar.2014.09.004. Epub 2014 Oct 2.

PMID:
27873692
8.

Prophylaxis of experimental endocarditis with antiplatelet and antithrombin agents: a role for long-term prevention of infective endocarditis in humans?

Veloso TR, Que YA, Chaouch A, Giddey M, Vouillamoz J, Rousson V, Moreillon P, Entenza JM.

J Infect Dis. 2015 Jan 1;211(1):72-9. doi: 10.1093/infdis/jiu426. Epub 2014 Aug 1.

PMID:
25086177
9.

Bactericidal synergism between daptomycin and the phage lysin Cpl-1 in a mouse model of pneumococcal bacteraemia.

Vouillamoz J, Entenza JM, Giddey M, Fischetti VA, Moreillon P, Resch G.

Int J Antimicrob Agents. 2013 Nov;42(5):416-21. doi: 10.1016/j.ijantimicag.2013.06.020. Epub 2013 Aug 9.

PMID:
23992647
10.

Streptococcus tigurinus is highly virulent in a rat model of experimental endocarditis.

Veloso TR, Zbinden A, Andreoni F, Giddey M, Vouillamoz J, Moreillon P, Zinkernagel AS, Entenza JM.

Int J Med Microbiol. 2013 Dec;303(8):498-504. doi: 10.1016/j.ijmm.2013.06.006. Epub 2013 Jun 20.

PMID:
23856340
11.

A positive interaction between inhibitors of protein synthesis and cefepime in the fight against methicillin-resistant Staphylococcus aureus.

Guignard B, Vouillamoz J, Giddey M, Moreillon P.

Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):899-907. doi: 10.1007/s10096-013-1824-x. Epub 2013 Jan 31.

PMID:
23370969
12.

Use of a human-like low-grade bacteremia model of experimental endocarditis to study the role of Staphylococcus aureus adhesins and platelet aggregation in early endocarditis.

Veloso TR, Chaouch A, Roger T, Giddey M, Vouillamoz J, Majcherczyk P, Que YA, Rousson V, Moreillon P, Entenza JM.

Infect Immun. 2013 Mar;81(3):697-703. doi: 10.1128/IAI.01030-12. Epub 2012 Dec 17.

13.

Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.

Moreillon P, Bizzini A, Giddey M, Vouillamoz J, Entenza JM.

J Antimicrob Chemother. 2012 Mar;67(3):652-60. doi: 10.1093/jac/dkr521. Epub 2011 Dec 13.

PMID:
22167243
14.

Continuous infusion may improve the efficacy of vancomycin in treatment of experimental endocarditis due to heterogeneous vancomycin-intermediate Staphylococcus aureus.

Pea F, Cojutti P, Petrosillo N, Furlanut M, Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P.

Antimicrob Agents Chemother. 2011 Sep;55(9):4496; author reply 4496-7. doi: 10.1128/AAC.00603-11. No abstract available.

15.

In vivo synergism of ceftobiprole and vancomycin against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Majcherczyk P, Moreillon P.

Antimicrob Agents Chemother. 2011 Sep;55(9):3977-84. doi: 10.1128/AAC.00402-11. Epub 2011 Jul 5.

16.

Induction of experimental endocarditis by continuous low-grade bacteremia mimicking spontaneous bacteremia in humans.

Veloso TR, Amiguet M, Rousson V, Giddey M, Vouillamoz J, Moreillon P, Entenza JM.

Infect Immun. 2011 May;79(5):2006-11. doi: 10.1128/IAI.01208-10. Epub 2011 Feb 14.

17.

Failure of vancomycin continuous infusion against experimental endocarditis due to vancomycin-intermediate Staphylococcus aureus.

Entenza JM, Veloso TR, Vouillamoz J, Giddey M, Moreillon P.

Antimicrob Agents Chemother. 2011 Jan;55(1):385-7. doi: 10.1128/AAC.00811-10. Epub 2010 Oct 18.

18.

In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin.

Entenza JM, Giddey M, Vouillamoz J, Moreillon P.

Int J Antimicrob Agents. 2010 May;35(5):451-6. doi: 10.1016/j.ijantimicag.2009.12.022. Epub 2010 Feb 24.

PMID:
20185277
19.

In vitro activities of tigecycline combined with other antimicrobials against multiresistant gram-positive and gram-negative pathogens.

Vouillamoz J, Moreillon P, Giddey M, Entenza JM.

J Antimicrob Chemother. 2008 Feb;61(2):371-4. Epub 2007 Nov 22.

PMID:
18033780
20.

Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.

Vouillamoz J, Moreillon P, Giddey M, Entenza JM.

J Antimicrob Chemother. 2006 Dec;58(6):1208-14. Epub 2006 Oct 9.

PMID:
17030515
21.

Genealogy of wine grape cultivars: "Pinot" is related to "Syrah".

Vouillamoz JF, Grando MS.

Heredity (Edinb). 2006 Aug;97(2):102-10. Epub 2006 May 24.

23.

Magnetic resonance sounding applied to aquifer characterization.

Legchenko A, Baltassat JM, Bobachev A, Martin C, Robain H, Vouillamoz JM.

Ground Water. 2004 May-Jun;42(3):363-73.

PMID:
15161153
24.

Efficacy of garenoxacin in treatment of experimental endocarditis due to Staphylococcus aureus or viridans group streptococci.

Entenza JM, Vouillamoz J, Glauser MP, Moreillon P.

Antimicrob Agents Chemother. 2004 Jan;48(1):86-92.

25.

Localization of saturated karst aquifer with magnetic resonance sounding and resistivity imagery.

Vouillamoz JM, Legchenko A, Albouy Y, Bakalowicz M, Baltassat JM, Al-Fares W.

Ground Water. 2003 Sep-Oct;41(5):578-86.

PMID:
13678112
26.

Microsatellite analysis of ancient alpine grape cultivars: pedigree reconstruction of Vitis vinifera L. 'Cornalin du Valais'.

Vouillamoz J, Maigre D, Meredith CP.

Theor Appl Genet. 2003 Aug;107(3):448-54. Epub 2003 May 7.

PMID:
12734654
27.

Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.

Marchetti O, Moreillon P, Entenza JM, Vouillamoz J, Glauser MP, Bille J, Sanglard D.

Antimicrob Agents Chemother. 2003 May;47(5):1565-70.

29.

Effect of compost in phytoremediation of diesel-contaminated soils.

Vouillamoz J, Milke MW.

Water Sci Technol. 2001;43(2):291-5.

PMID:
11380193
31.

Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis.

Entenza JM, Vouillamoz J, Glauser MP, Moreillon P.

Antimicrob Agents Chemother. 1999 Jan;43(1):77-84.

32.
33.

Efficacy of clarithromycin versus that of clindamycin for single-dose prophylaxis of experimental streptococcal endocarditis.

Vermot D, Entenza JM, Vouillamoz J, Glauser MP, Moreillon P.

Antimicrob Agents Chemother. 1996 Mar;40(3):809-11.

Supplemental Content

Loading ...
Support Center